Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 51 results.
User Information
Export Records
  1. 1.   Clathrin light chain A drives selective myosin VI recruitment to clathrin-coated pits under membrane tension
  2. Biancospino, Matteo; Buel,Gwen; Niño, Carlos A; Maspero, Elena; di Perrotolo, Rossella Scotto; Raimondi, Andrea; Redlingshöfer, Lisa; Weber, Janine; Brodsky, Frances M; Walters,Kylie; Polo, Simona
  3. Nature communications. 2019, Oct 31; 10(1): 4974.
  1. 2.   Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
  2. Saleh, Anthony D.; Cheng, Hui; Martin, Scott E.; Si, Han; Ormanoglu, Pinar; Carlson, Sophie; Clavijo, Paul E.; Yang, Xinping; Das, Rita; Cornelius, Shaleeka; Couper, Jamie; Chepeha, Douglas; Danilova, Ludmila; Harris, Thomas M.; Prystowsky, Michael B.; Childs, Geoffrey J.; Smith, Richard; Robertson, A. Gordon; Jones, Steven J. M.; Cherniack, Andrew D.; Kim, Sang S.; Rait, Antonina; Pirollo, Kathleen F.; Chang, Esther H.; Chen, Zhong; Van Waes, Carter
  3. CLINICAL CANCER RESEARCH. 2019, MAY 1; 25(9): 2860-2873.
  1. 3.   Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
  2. Nussinov,Ruth; Jang,Hyunbum; Tsai,Chung-Jung; Cheng, Feixiong
  3. PLoS computational biology. 2019, Mar; 15(3):
  1. 4.   Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
  2. Shirey, Kari Ann; Sunday, Mary E.; Lai, Wendy; Patel, Mira C.; Blanco, Jorge C. G.; Cuttitta,Frank; Vogel, Stefanie N.
  3. Mucosal immunology. 2019, Jan; 12(1): 223-231.
  1. 5.   Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers
  2. Kawakami, Masanori; Mustachio, Lisa Maria; Liu, Xi; Dmitrovsky, Ethan
  3. Molecular Cancer Therapeutics. 2018, Apr; 17(4): 724-731.
  1. 6.   Regulation of inflammation by members of the formyl-peptide receptor family
  2. Chen, Keqiang; Bao, Zhiyao; Gong, Wang; Tang, Peng; Yoshimura, Teizo; Wang, Jiming
  3. JOURNAL OF AUTOIMMUNITY. 2017, DEC; 85: 64-77.
  1. 7.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 8.   RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
  2. Lipkowitz, S.; Weissman, A. M.
  3. Nature Reviews Cancer. 2011, Sep; 11(9): 629-643.
  1. 9.   Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies
  2. Gursel, D. B.; Connell-Albert, Y. S.; Tuskan, R. G.; Anastassiadis, T.; Walrath, J. C.; Hawes, J. J.; Amlin-Van Schaick, J. C.; Reilly, K. M.
  3. Neuro-Oncology. 2011, Jun; 13(6): 610-621.
  1. 10.   CCAAT/Enhancer-Binding Proteins (C/EBP)-alpha and -beta Are Essential for Ovulation, Luteinization, and the Expression of Key Target Genes
  2. Fan, H. Y.; Liu, Z. L.; Johnson, P. F.; Richards, J. S.
  3. Molecular Endocrinology. 2011, Feb; 25(2): 253-268.
  1. 11.   Back to the Future: Proceedings From the 2010 NF Conference
  2. Huson, S. M.; Acosta, M. T.; Belzberg, A. J.; Bernards, A.; Chernoff, J.; Cichowski, K.; Evans, D. G.; Ferner, R. E.; Giovannini, M.; Korf, B. R.; Listernick, R.; North, K. N.; Packer, R. J.; Parada, L. F.; Peltonen, J.; Ramesh, V.; Reilly, K. M.; Risner, J. W.; Schorry, E. K.; Upadhyaya, M.; Viskochil, D. H.; Zhu, Y. A.; Hunter-Schaedle, K.; Giancotti, F. G.
  3. American Journal of Medical Genetics Part A. 2011, Feb; 155A(2): 307-321.
  1. 12.   Role of IKK alpha in skin squamous cell carcinomas
  2. Park, E. M.; Liu, B. G.; Xia, X. J.; Zhu, F.; Jami, W. B.; Hu, Y. L.
  3. Future Oncology. 2011, Jan; 7(1): 123-134.
  1. 13.   The odyssey of marine pharmaceuticals: a current pipeline perspective
  2. Mayer, A. M. S.; Glaser, K. B.; Cuevas, C.; Jacobs, R. S.; Kem, W.; Little, R. D.; McIntosh, J. M.; Newman, D. J.; Potts, B. C.; Shuster, D. E.
  3. Trends in Pharmacological Sciences. 2010, Jun; 31(6): 255-265.
  1. 14.   Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
  2. Moody, T. W.; Switzer, C.; Santana-Flores, W.; Ridnour, L. A.; Berna, M.; Thill, M.; Jensen, R. T.; Sparatore, A.; Del Soldato, P.; Yeh, G. C.; Roberts, D. D.; Giaccone, G.; Wink, D. A.
  3. Lung Cancer. 2010, May; 68(2): 154-160.
  1. 15.   Inheritance of susceptibility to induction of nephroblastomas in the Noble rat
  2. Diwan, B. A.; Timofeeva, O.; Rice, J. M.; Yang, Y. L.; Sharma, N.; Fortini, M. E.; Wang, H. H.; Perantoni, A. O.
  3. Differentiation. 2009, Apr; 77(4): 424-432.
  1. 16.   A tale of terminal differentiation IKK alpha, the master keratinocyte regulator
  2. Liu, B. G.; Zhu, F.; Xia, X. J.; Park, E.; Hu, Y. L.
  3. Cell Cycle. 2009 8(4): 527-531.
  1. 17.   Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen
  2. Rahrmann, E. P.; Collier, L. S.; Knutson, T. P.; Doyal, M. E.; Kuslak, S. L.; Green, L. E.; Malinowski, R. L.; Roethe, L.; Akagi, K.; Waknitz, M.; Huang, W.; Largaespada, D. A.; Marker, P. C.
  3. Cancer Research. 2009 69(10): 4388-4397.
  1. 18.   Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
  2. Taylor, J. G.; Cheuk, A. T.; Tsang, P. S.; Chung, J. Y.; Song, Y. K.; Desai, K.; Yu, Y. L.; Chen, Q. R.; Shah, K.; Youngblood, V.; Fang, J.; Kim, S. Y.; Yeung, C.; Helman, L. J.; Mendoza, A.; Ngo, V.; Staudt, L. M.; Wei, J. S.; Khanna, C.
  3. Journal of Clinical Investigation. 2009 119(11): 3395-3407.
  1. 19.   IKK alpha is required to maintain skin homeostasis and prevent skin cancer
  2. Liu, B. G.; Xia, X. J.; Zhu, F.; Park, E.; Carbajal, S.; Kiguchi, K.; DiGiovanni, J.; Fischer, S. M.; Hu, Y. L.
  3. Cancer Cell. 2008 14(3): 212-225.
  1. 20.   In vitro efficacy of immuno-chemotherapy with anti-EGFR human fab-taxol conjugate on A431 epidermoid carcinoma cells
  2. Wang, X.; Zhu, J.; Zhao, P.; Jiao, Y. G.; Xu, N.; Grabinski, T.; Liu, C.; Miranti, C. K.; Fu, T.; Cao, B. B.
  3. Cancer Biology & Therapy. 2007, Jun; 6(6): 980-986.
  1. 21.   Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
  2. Palmieri, D.; Bronder, J. L.; Herring, J. M.; Yoneda, T.; Weil, R. J.; Stark, A. M.; Kurek, R.; Vega-Valle, E.; Feigenbaum, L.; Halverson, D.; Vortmeyer, A. O.; Steinberg, S. M.; Aldape, K.; Steeg, P. S.
  3. Cancer Research. 2007, May; 67(9): 4190-4198.
  1. 22.   Four independent mutations in the feline Fibroblast Growth Factor 5 gene determine the long-haired phenotype in domestic cats
  2. Kehler, J. S.; David, V. A.; Schaffer, A. A.; Bajema, K.; Eizirik, E.; Ryugo, D. K.; Hannah, S. S.; O'Brien, S. J.; Menotti-Raymond, M.
  3. Journal of Heredity. 2007, Sep-Oct; 98(6): 555-566.
  1. 23.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 24.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 25.   Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles
  2. Oishi, S.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2005, APR; 6(4): 668-674.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel